alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
EXHIBIT 31.2

Certification

I, Sridhar Ganesan, certify that:

1. I have reviewed this quarterly report on Form 10-Q for the quarter ended September 30, 2007 of WorldSpace, Inc.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary
to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all
material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrants other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant
and have:

a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be
designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is
being prepared;

b) Evaluated the effectiveness of the registrants disclosure controls and procedures and presented in
this report our conclusions about the effectiveness of the disclosure controls and procedures as of the end of the period covered by this report based on our evaluation; and

c) Disclosed in this report any change in the registrants internal control over financial reporting that occurred during the
registrants most recent fiscal quarter (the registrants fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrants internal control over
financial reporting; and

5. The registrants other certifying officer and I have disclosed, based on our most recent
evaluation of internal control over financial reporting, to the registrants auditors and the audit committee of the registrants board of directors (or persons performing the equivalent functions):

a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are
reasonably likely to adversely affect the registrants ability to record, process, summarize and report financial information; and

b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrants internal control over financial reporting.

Date: November 13, 2007



/S/ SRIDHAR GANESANSridhar Ganesan Executive Vice PresidentChief Financial Officer
EXHIBIT 4.1

NUMBER                                                                    SHARES
SPECIMEN                                                                SPECIMEN

                            SALES ONLINE DIRECT, INC.
              INCORPORATED UNDER THE LAWS OF THE STATE OF DELAWARE

                                  COMMON STOCK

This Certifies That:                                              CUSIP 3216-009
                                    SPECIMEN

Is Owner of

 FULLY PAID AND NON-ASSESSABLE SHARES OF COMMON STOCK OF $.001 PAR VALUE EACH OF
                            Sales Online Direct, Inc.
transferable  on the books of the  Corporation  in person  or by  attorney  upon
surrender of this  certificate  duly endorsed or assigned.  This certificate and
the shares  represented hereby are subject to the laws of the State of Delaware,
and to the Certificate of Incorporation and Bylaws of the Corporation, as now or
hereafter  amended.  This  certificate is not valid until  countersigned  by the
Transfer Agent.
         WITNESS  the  facsimile  seal  of the  Corporation  and  the  facsimile
signatures of its duly authorized officers.

DATED:                     COUNTERSIGNED:
                               OLDE MONMOUTH STOCK TRANSFER CO., INC.
                               77 MEMORIAL PARKWAY, ATLANTIC HIGHLANDS, NJ 07716
        SEAL                                TRANSFER AGENT

                                            AUTHORIZED SIGNATURE

SECRETARY                      CHAIRMAN
[Federal Register Volume 61, Number 109 (Wednesday, June 5, 1996)]
[Notices]
[Page 28601]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 96-14040]



-----------------------------------------------------------------------

DEPARTMENT OF LABOR
[Notice (90-056)]


NASA Advisory Council, Life and Microgravity Sciences and 
Applications Advisory Committee, NASA-NIH Advisory Subcommittee on 
Behavioral and Biomedical Research; Meeting

agency: National Aeronautics and Space Administration.

action: Notice of meeting.

-----------------------------------------------------------------------

summary: In accordance with the Federal Advisory Committee Act, Pub. L. 
92-463, as amended, the National Aeronautics and Space Administration 
announces a meeting of the NASA Advisory Council, Life and Microgravity 
Sciences and Applications Advisory Committee, NASA-NIH Advisory 
Subcommittee on Behavioral and Biomedical Research.

dates: June 20, 1996, 12:30 p.m. to 5:30 p.m.; and June 21, 1996, 8:30 
a.m. to 3:00 p.m.

addresses: Cocoa Beach Hilton, 1550 North Atlantic Avenue, Cocoa Beach, 
Florida 32930.

for further information contact: Dr. Arnauld Nicogossian, Code U, 
National Aeronautics and Space Administration, Washington, DC 20546, 
202/358-0215.

supplementary information: The meeting will be closed to the public on 
Thursday, June 20, 1996, from 5:00 p.m. to 5:30 p.m. in accordance with 
5 U.S.C. 552b(c)(6), to allow for discussion on qualifications of 
individuals being considered for membership to the Committee. The 
remainder of the meeting will be open to the public up to the seating 
capacity of the room. The agenda for the meeting is as follows:

--Review of the Office of Life and Microgravity Sciences and 
Applications Status
--Status of NASA-NIH Activities
--Global Health and Remote Sensing
--Behavioral Studies
--International Space Station
--Science Institutes
--Pharmacology
--Committee Discussion Regarding Future Activities

    It is imperative that the meeting be held on these dates to 
accommodate the scheduling priorities of the key participants. Visitors 
will be requested to sign a visitor's register.

    Dated: May 29, 1996.
Leslie M. Nolan,
Advisory Committee Management Officer, National Aeronautics and Space 
Administration.
[FR Doc. 96-14040 Filed 6-4-96; 8:45 am]
BILLING CODE 7510-01-M
#### Gloria RABINES, Plaintiff/Appellant, v. Jose RABINES, Defendant/Respondent.

No. 68038.

Missouri Court of Appeals, Eastern District, Division Four.

March 26, 1996.

Fortus, Anderson & Rivera, Rodolfo Rivera, Clayton, for appellant.

Byron Cohen, Clayton, for respondent.

Before AHRENS, P.J., and PUDLOWSKI and GRIMM, JJ.

*ORDER*

PER CURIAM.

Appellant appeals a dismissal of her cause of action by the trial court on the grounds that she was barred by collateral estoppel.

We have read the briefs, reviewed the legal file and transcript. We further reexamined the rule of collateral estoppel. We find no error of law and no jurisprudential purpose would be served by an extended written opinion. Judgment affirmed in accordance with Rule 84.16(b).
AMENDMENT  TO  THE
SERVICE  AGREEMENT

Between

1)     Axel  Kleinkorres  Promotionsagentur,  proprietor  Axel  Kleinkorres,
registered  offices  at M  nsterstr.  306 D-40470  D  sseldorf

-     referred  to  hereinafter  as  Promotion  agency"  -

and

2)     Sangui  BioTech  International,  Inc.,  registered  offices  at
1508  Brockhollow  Drive,  Suite  354, Santa  Ana,  California  92705,  USA
represented  by  Prof.  Dr.  Dr.  Wolfgang  Barnikol,  President  and  CEO
-     referred  to  hereinafter  as  "Sangui"  -



ARTICLE   1  EXTENSION  OF  THE  AGREEMENT

The  contracting  parties  hereby agree that the service agreement  of April 26,
1999 shall be extended until December 31, 2002. All services rendered so far and
still  to  be  rendered  under  this  agreement have already been settled by the
consideration  as  agreed.


ARTICLE   2


As  for  the  rest, the parties agree that the agreement of April 26, 1999 shall
not  be  amended  any  further.





Dusseldorf,  August  18,  2000


Axel  Kleinkorres  Promotionsagentur          Sangui BioTech International, Inc.


(Signature)                                   (Signature)
_____________________________                 ______________________________
Axel  Kleinkorres                             Prof.  Dr.  Dr. Wolfgang Barnikol
                                              President  and  CEO
[Federal Register Volume 61, Number 18 (Friday, January 26, 1996)]
[Proposed Rules]
[Pages 2464-2465]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 96-1403]



-----------------------------------------------------------------------

[[Page 2465]]



ENVIRONMENTAL PROTECTION AGENCY
40 CFR Part 70

[AD-FRL-5404-5 ]


Clean Air Act Proposed Interim Approval of Operating Permits 
Program; Maryland; Extension of the Comment Period

AGENCY: Environmental Protection Agency (EPA).

ACTION: Proposed rule; extension of the comment period.

-----------------------------------------------------------------------

SUMMARY: EPA reopened the comment period for a notice published on 
October 30, 1995 (60 FR 55231). In the October 30 notice, EPA proposed 
an interim approval of the operating permits program submitted by 
Maryland because the program substantially, but not fully, met the 
requirements of Part 70.
    At the request of the SIERRA CLUB--Maryland Chapter, Maryland 
Public Interest Research Group, and the American Lung Association of 
Maryland, EPA reopened the comment period through December 29, 1995. 
All comments received on or before December 29 were entered into the 
public record and will be considered by EPA before taking final action 
on the proposed rule.

DATES: Comments were to have been received on or before December 29, 
1995.

ADDRESSES: Comments were to have been mailed to Marcia L. Spink, 
Associate Director, Air Programs, Mailcode 3AT00, U.S. Environmental 
Protection Agency, Region III, 841 Chestnut Building, Philadelphia, 
Pennsylvania 19107.

FOR FURTHER INFORMATION CONTACT: Enid A. Gerena, U.S. EPA Region III, 
(215) 597-8239.

    Dated: December 8, 1995.
Stanley Laskowski,
Acting Regional Administrator, Region III.
[FR Doc. 96-1403 Filed 1-25-96; 8:45 am]
BILLING CODE 6560-50-P
Exhibit No. 31.1





CERTIFICATION





I, Vincent Beatty, certify that:





1. I have reviewed this quarterly Report on Form 10-Q of Smitten Press: Local Lore and Legends, Inc.;





2. Based on my knowledge, this quarterly report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this quarterly report;





3. Based on my knowledge, the financial statements, and other financial information included in this quarterly report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this quarterly report;





4. The issuer's other certifying officers and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the issuer and have:





(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the issuer, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this quarterly report is being prepared;





(b) Evaluated the effectiveness of the issuer's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and





(c) Disclosed in this report any change in the issuer's internal control over financial reporting that occurred during the issuer's most recent fiscal quarter (the issuer's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the issuer's internal control over financial reporting; and





5. The issuer's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the issuer's auditors and the audit committee of the issuer's board of directors (or persons performing the equivalent functions):





(a) All significant deficiencies and material weaknesses in the design or operation of internal controls over financial reporting which are reasonably likely to adversely affect the issuer's ability to record, process, summarize and report financial information; and





(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the issuer's internal control over financial reporting.





Date: July 15, 2010





By  /s/ VINCENT BEATTY


Vincent Beatty, Director


(Acting as Principal Executive and Financial Officer)
NOT FOR PUBLICATION

UNITED STATES COURT OF APPEALS

FOR THE NINTH CIRCUIT

ROGER DAVID TOWERS; CATHERINE TOWERS,

Plaintiffs

- Appellants,

v.
JAMES MARK MYLES; et al.,

Defendants

- Appellees. No. 19

- 16684

D.C. No. 2:18

- cv

- 02996

- JAM

- KJN

MEMORANDUM *

Appeal from the United States District Court for the Eastern District of California John A. Mendez, District Judge, Presiding

Submitted February 17, 2021 * *

Before: FERNANDEZ
, BYBEE , and BADE
, Circuit Judges

. Roger David Towers and Catherine Towers appeal pro se from the district

court’s judgment dismissing their action alleging federal claims related to the land

use designation of their property and a restraining order against Mr. Towers. We

have jurisdiction under 28 U.S.C. § 1291. We affirm.

* This disposition is not appropriate for publication and is not precedent except as provided by Ninth Circuit Rule 36

- 3.

** The panel unanimously concludes this case is suitable for decision without oral argument. See Fed. R. App. P. 34(a)(2). 

# FILED

FEB 23 2021

MOLLY C. DWYER, CLERK U.S. COURT OF APPEALS2 19

- 16684

In their opening brief, plaintiffs fail to raise, and therefore have waived, any

challenge to the district court’s dismissal of their action as barred by claim and

issue preclusion

. See Indep. Towers of Wash. v. Washin gton , 350 F.3d 925, 929

(9th Cir. 2003) (“[W]e will not consider any claims that were not actually argued

in appellant’s opening brief.”); Acosta

- Huerta v. Estelle , 7 F.3d 139, 144 (9th Cir.

1993) (issues not supported by argument in pro se appellant’s ope ning brief are

waived).

On February 28, 2020, a panel denied plaintiffs’ motion for disqualification

of the magistrate judge and district judge. The February 28, 2020 order further

stated that “[n]o motions for reconsideration, clarification, or modificat ion of this

denial shall be filed or entertained,” and that plaintiffs should not raise these same

arguments in the opening brief. Accordingly, we do not consider plaintiffs’

contentions related to the issue of recusal of the magistrate judge and district judge

. We reject as without merit plaintiffs’ contentions that the district judge

failed to conduct a de novo review of the magistrate judge’s findings and

recommendations, and that the action was erroneously referred to the jurisdiction

of the magistrate judge.

We do not consider matters not specifically and distinctly raised and argued

in the opening brief. See Padgett v. Wright , 587 F.3d 983, 985 n.2 (9th Cir. 2009).

AFFIRMED.
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25

31

OF BY MR. CHAMI: What makes you think
Mr. Muhaymin was going to die from meth on January 4th,
AOU?
MS. STILLWELL: Argumentative, speculative,
leading.
THE WITNESS: Methamphetamine is a drug that
has unpredictable effects, again, no safe level, so if

you're using it, there's always the potential for it to

be fatal.
Q. BY MR. CHAMI: I mean, aspirin can be fatal,
right?
MS. STILLWELL: Objection.
THE WITNESS: Yes.
MS. STILLWELL: Argumentative.
Q. BY MR. CHAMI: Okay. How about coronary

heart disease? Is that something that Mr. Muhaymin was
likely to die from on January 4th, 2017, absent
physical exertion during law enforcement subdual?

MS. STILLWELL: Argumentative, speculative
and leading.

THE WITNESS: So coronary artery disease, and
it's possible, I would say less likely.

Q. BY MR. CHAMI: Okay. Do you know how many

people in the United States have -- over the age of 20

have coronary artery disease?



EXHIBIT 53


10
11
12
13
14
15
16
17
18
19
20
21
22
23
24

25

IN THE UNITED STATES DISTRICT COURT

FOR THE DISTRICT OF ARIZONA

Mussalina Muhaymin,
Plaintiff,

vs. Case No.

CV-17-04565-PHX-SMB
City of Phoenix, et al.,

Defendants.

DEPOSITION OF AMANDA E. MASKOVYAK, M.D.
(VIA ZOOM)

(CONFIDENTIAL)

Phoenix, Arizona
May 26, 2020

1:00 p.m.
Prepared by: BB&S REPORTING LLC
Pamela Joy Giffin, RPR 2415 East Camelback Road
Arizona CR No. 50106 Suite 700
California CSR No. 8651 Phoenix, Arizona 85016

602-883-8390
officetébbsreporting.com



10
11
12
13
14
15
16
17
18
19
20
21
22
23
24

25

30

would need to understand that individual's tolerance
and history of usage, right?

MS. STILLWELL: Speculative, argumentative,

leading.
Q. BY MR. CHAMI: Correct?
A. I would say not necessarily.
OF BY MR. CHAMI: So you're saying that you can

to a reasonable degree of medical certainty determine
based on the levels of methamphetamine in a person and
no other information, you'd be able to render a
medically certain opinion as to the impact of the meth
on that individual?

MS. STILLWELL: Same objection.

THE WITNESS: Yes. Methamphetamine is
considered a drug with no safe levels.

Q. BY MR. CHAMI: How many people -- do you know

how many people use meth in the United States each

year?
MS. STILLWELL: Form and foundation.
THE WITNESS: No.
Q. BY MR. CHAMI: Do you know how many people

die from meth in the United States each year?
MS. STILLWELL: Same objection.
Argumentative, relevance, foundation.

THE WITNESS: No.
1 

2 

3 

4 

5 

6 

7 

8 

9 

10 

11 

12 

13 

14 

15 

16 

17 

18 

19 

20 

21 

22 

23 

24 

25 

26 

27 

28 

IN THE UNITED STATES DISTRICT COURT 

FOR THE DISTRICT OF ARIZONA 

Fernando Gastelum, 

Plaintiff, 

v. 

Chandler & Kyrene Hotel Group LLC, 

Defendant. 

NO. CV-17-04089-PHX-DJH

AMENDED1

 JUDGMENT 

 IN A CIVIL CASE 

 Pursuant to Plaintiff having accepted Defendant's offer of judgment, judgment is 

hereby entered against Defendant Chandler & Kyrene Hotel Group LLC as follows: 

1. Defendant will (within 60 days) identify and describe on its website accessible 

features found in each of the following areas of the hotel: (1) Parking and Loading 

Zone; (2) Exterior Routes; (3) Building Entrances and Lobby; (4) Interior Routes; 

(5) Public/Common Use Restrooms; (6) Accessible Guestrooms and Suites; (7) 

Accessible Guestroom Bathrooms; and (8) Pool/Spa area. 

2. Defendant will (within 60 days) communicate the above referenced accessible 

features to all third party booking agents who facilitate online or telephonic 

reservations for Defendant's hotel. Defendant shall provide Plaintiff with a copy of 

this communication. 

 3. Defendant will (within 60 days) modify its policies, practices and procedures to 

 

1

 Amended to correct defendant name in line 16. 

Case 2:17-cv-04089-DJH Document 19 Filed 02/20/18 Page 1 of 2
- 2 - 

1 

2 

3 

4 

5 

6 

7 

8 

9 

10 

11 

12 

13 

14 

15 

16 

17 

18 

19 

20 

21 

22 

23 

24 

25 

26 

27 

28 

ensure that individuals who require mobility and/or ambulatory assistance can make 

reservations for accessible guest rooms during the same hours and in the same 

manner as individuals who do not require mobility and/or ambulatory assistance. 

Defendant shall provide Plaintiff with a copy of the modified policies, practices and 

procedures referenced herein. 

4. Defendant shall (within 90 days) identify mobility accessibility features at its hotel 

that do not comply with the 2010 Standards of Accessibility Design and shall, 

within 12 months, remove barriers to mobility accessibility to the extent that such 

removal is readily achievable. 

 This matter is hereby terminated.

 Brian D. Karth

 District Court Executive/Clerk of Court

February 20, 2018 

s/ Leann Dixon

 By Deputy Clerk

 

Case 2:17-cv-04089-DJH Document 19 Filed 02/20/18 Page 2 of 2
#### STATE of Missouri, Respondent, v. Larry W. DUDLEY, Appellant.

No. WD 46775.

Missouri Court of Appeals, ' Western District.

April 13, 1993.

Art Tejeda, Columbia, for appellant.

Robert R. Sterner, Fulton, for respondent.

Before ULRICH, P.J., and BRECKENRIDGE and HANNA, JJ.

ORDER

PER CURIAM:

Appeal from convictions of driving while intoxicated, section 577.010, RSMo 1986, and property damage in the second degree, section 569.120, RSMo 1986, and from two consecutive sentences of six months’ confinement and fines imposed by the court.

Judgment affirmed. Rule 30.25(b).
Case 2:17-cr-01407-JAT Document 1 Filed 09/18/17 Page 1 of 4
Case 2:17-cr-01407-JAT Document 1 Filed 09/18/17 Page 2 of 4
Case 2:17-cr-01407-JAT Document 1 Filed 09/18/17 Page 3 of 4
Case 2:17-cr-01407-JAT Document 1 Filed 09/18/17 Page 4 of 4